Loading…

Barriers of Care to Ovarian Cancer: A Scoping Review

Ovarian cancer is a leading cause of female cancer-related deaths, but patients continue to be diagnosed late. This subjects them to disease progression and possible death due to lack of early detection, despite earlier stage detection improving survival rates by significant percentages. Early detec...

Full description

Saved in:
Bibliographic Details
Published in:Curēus (Palo Alto, CA) CA), 2023-06, Vol.15 (6), p.e40309-e40309
Main Authors: Rizvi, Zehra, Sharma, Kiran C, Kunder, Viktor, Abreu, Adrian
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites cdi_FETCH-LOGICAL-c300t-d8f1f42a83549bf412114d954d1c602e378c238df473c68804a125164d1b683c3
container_end_page e40309
container_issue 6
container_start_page e40309
container_title Curēus (Palo Alto, CA)
container_volume 15
creator Rizvi, Zehra
Sharma, Kiran C
Kunder, Viktor
Abreu, Adrian
description Ovarian cancer is a leading cause of female cancer-related deaths, but patients continue to be diagnosed late. This subjects them to disease progression and possible death due to lack of early detection, despite earlier stage detection improving survival rates by significant percentages. Early detection and access to care are closely related. However, many barriers to high-quality care exist for patients and the majority of patients do not receive recommended care according to ovarian cancer treatment guidelines. In order to improve care for ovarian cancer patients and decrease healthcare disparities in accessing equitable care, it is important to acknowledge the current gaps in patient knowledge, healthcare availability, and physician practice. This scoping review explores the available evidence on ovarian cancer to identify these barriers to care in the effective treatment of ovarian cancer. Using both inclusion and exclusion criteria, results from the initial literature search were screened by the authors. After quality assessment and screening for relevance, 10 articles were included in the final review. The following themes emerged as barriers to care: hospital and physician-patient volumes, geographic distance from care facilities, patient and physician education, and demographic factors. Many patients were found to not receive guideline adherent care due to various barriers to care, whereas guideline adherent care was independently associated with factors such as patient proximity to a high-volume hospital, White race, and higher socioeconomic status. Several areas were identified as potential for increased patient and physician education, including treatment complications and patient resources. The evidence found that certain socioeconomic groups and racial minorities are often at higher risk for guideline non-adherent care. Additionally, the evidence showed a further need for physicians and healthcare providers to be provided with resources for post-cancer treatment, follow-up, and patient education. The findings of this review will provide health experts and patients with better insight into what barriers may exist so that guideline-adherent care can be better advocated for and met.
doi_str_mv 10.7759/cureus.40309
format article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10337512</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2844012455</sourcerecordid><originalsourceid>FETCH-LOGICAL-c300t-d8f1f42a83549bf412114d954d1c602e378c238df473c68804a125164d1b683c3</originalsourceid><addsrcrecordid>eNpdkc1Lw0AQxRdRbKm9eZaAFw-m7uxOko0XqcUvKBT8OC_bzaampNm6m1T8701tLdXTzPB-PObxCDkFOkiSKL3SjTONHyDlND0gXQaxCAUIPNzbO6Tv_ZxSCjRhNKHHpMMTRIEMugRvlXOFcT6weTBSzgS1DSYr5QpVtXeljbsOhsGLtsuimgXPZlWYzxNylKvSm_529sjb_d3r6DEcTx6eRsNxqDmldZiJHHJkSvAI02mOwAAwSyPMQMeUGZ4IzbjIcky4joWgqIBFELf6NBZc8x652fgum-nCZNpUtVOlXLpiodyXtKqQf5WqeJczu5JAOU8iYK3DxdbB2Y_G-FouCq9NWarK2MZLJrhgCDyOWvT8Hzq3javafC2FSIFhtKYuN5R21ntn8t03QOW6ErmpRP5U0uJn-wl28G8B_BtdN4UP</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2844012455</pqid></control><display><type>article</type><title>Barriers of Care to Ovarian Cancer: A Scoping Review</title><source>Open Access: PubMed Central</source><source>Publicly Available Content (ProQuest)</source><creator>Rizvi, Zehra ; Sharma, Kiran C ; Kunder, Viktor ; Abreu, Adrian</creator><creatorcontrib>Rizvi, Zehra ; Sharma, Kiran C ; Kunder, Viktor ; Abreu, Adrian</creatorcontrib><description>Ovarian cancer is a leading cause of female cancer-related deaths, but patients continue to be diagnosed late. This subjects them to disease progression and possible death due to lack of early detection, despite earlier stage detection improving survival rates by significant percentages. Early detection and access to care are closely related. However, many barriers to high-quality care exist for patients and the majority of patients do not receive recommended care according to ovarian cancer treatment guidelines. In order to improve care for ovarian cancer patients and decrease healthcare disparities in accessing equitable care, it is important to acknowledge the current gaps in patient knowledge, healthcare availability, and physician practice. This scoping review explores the available evidence on ovarian cancer to identify these barriers to care in the effective treatment of ovarian cancer. Using both inclusion and exclusion criteria, results from the initial literature search were screened by the authors. After quality assessment and screening for relevance, 10 articles were included in the final review. The following themes emerged as barriers to care: hospital and physician-patient volumes, geographic distance from care facilities, patient and physician education, and demographic factors. Many patients were found to not receive guideline adherent care due to various barriers to care, whereas guideline adherent care was independently associated with factors such as patient proximity to a high-volume hospital, White race, and higher socioeconomic status. Several areas were identified as potential for increased patient and physician education, including treatment complications and patient resources. The evidence found that certain socioeconomic groups and racial minorities are often at higher risk for guideline non-adherent care. Additionally, the evidence showed a further need for physicians and healthcare providers to be provided with resources for post-cancer treatment, follow-up, and patient education. The findings of this review will provide health experts and patients with better insight into what barriers may exist so that guideline-adherent care can be better advocated for and met.</description><identifier>ISSN: 2168-8184</identifier><identifier>EISSN: 2168-8184</identifier><identifier>DOI: 10.7759/cureus.40309</identifier><identifier>PMID: 37448421</identifier><language>eng</language><publisher>United States: Cureus Inc</publisher><subject>Cancer therapies ; Epidemiology/Public Health ; Health care access ; Health disparities ; Mortality ; Obstetrics/Gynecology ; Oncology ; Ovarian cancer ; Quality of care ; Socioeconomic factors ; Womens health</subject><ispartof>Curēus (Palo Alto, CA), 2023-06, Vol.15 (6), p.e40309-e40309</ispartof><rights>Copyright © 2023, Rizvi et al.</rights><rights>Copyright © 2023, Rizvi et al. This work is published under https://creativecommons.org/licenses/by/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>Copyright © 2023, Rizvi et al. 2023 Rizvi et al.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c300t-d8f1f42a83549bf412114d954d1c602e378c238df473c68804a125164d1b683c3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.proquest.com/docview/2844012455/fulltextPDF?pq-origsite=primo$$EPDF$$P50$$Gproquest$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/2844012455?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,25752,27923,27924,37011,37012,44589,53790,53792,74897</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/37448421$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Rizvi, Zehra</creatorcontrib><creatorcontrib>Sharma, Kiran C</creatorcontrib><creatorcontrib>Kunder, Viktor</creatorcontrib><creatorcontrib>Abreu, Adrian</creatorcontrib><title>Barriers of Care to Ovarian Cancer: A Scoping Review</title><title>Curēus (Palo Alto, CA)</title><addtitle>Cureus</addtitle><description>Ovarian cancer is a leading cause of female cancer-related deaths, but patients continue to be diagnosed late. This subjects them to disease progression and possible death due to lack of early detection, despite earlier stage detection improving survival rates by significant percentages. Early detection and access to care are closely related. However, many barriers to high-quality care exist for patients and the majority of patients do not receive recommended care according to ovarian cancer treatment guidelines. In order to improve care for ovarian cancer patients and decrease healthcare disparities in accessing equitable care, it is important to acknowledge the current gaps in patient knowledge, healthcare availability, and physician practice. This scoping review explores the available evidence on ovarian cancer to identify these barriers to care in the effective treatment of ovarian cancer. Using both inclusion and exclusion criteria, results from the initial literature search were screened by the authors. After quality assessment and screening for relevance, 10 articles were included in the final review. The following themes emerged as barriers to care: hospital and physician-patient volumes, geographic distance from care facilities, patient and physician education, and demographic factors. Many patients were found to not receive guideline adherent care due to various barriers to care, whereas guideline adherent care was independently associated with factors such as patient proximity to a high-volume hospital, White race, and higher socioeconomic status. Several areas were identified as potential for increased patient and physician education, including treatment complications and patient resources. The evidence found that certain socioeconomic groups and racial minorities are often at higher risk for guideline non-adherent care. Additionally, the evidence showed a further need for physicians and healthcare providers to be provided with resources for post-cancer treatment, follow-up, and patient education. The findings of this review will provide health experts and patients with better insight into what barriers may exist so that guideline-adherent care can be better advocated for and met.</description><subject>Cancer therapies</subject><subject>Epidemiology/Public Health</subject><subject>Health care access</subject><subject>Health disparities</subject><subject>Mortality</subject><subject>Obstetrics/Gynecology</subject><subject>Oncology</subject><subject>Ovarian cancer</subject><subject>Quality of care</subject><subject>Socioeconomic factors</subject><subject>Womens health</subject><issn>2168-8184</issn><issn>2168-8184</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><sourceid>PIMPY</sourceid><recordid>eNpdkc1Lw0AQxRdRbKm9eZaAFw-m7uxOko0XqcUvKBT8OC_bzaampNm6m1T8701tLdXTzPB-PObxCDkFOkiSKL3SjTONHyDlND0gXQaxCAUIPNzbO6Tv_ZxSCjRhNKHHpMMTRIEMugRvlXOFcT6weTBSzgS1DSYr5QpVtXeljbsOhsGLtsuimgXPZlWYzxNylKvSm_529sjb_d3r6DEcTx6eRsNxqDmldZiJHHJkSvAI02mOwAAwSyPMQMeUGZ4IzbjIcky4joWgqIBFELf6NBZc8x652fgum-nCZNpUtVOlXLpiodyXtKqQf5WqeJczu5JAOU8iYK3DxdbB2Y_G-FouCq9NWarK2MZLJrhgCDyOWvT8Hzq3javafC2FSIFhtKYuN5R21ntn8t03QOW6ErmpRP5U0uJn-wl28G8B_BtdN4UP</recordid><startdate>20230612</startdate><enddate>20230612</enddate><creator>Rizvi, Zehra</creator><creator>Sharma, Kiran C</creator><creator>Kunder, Viktor</creator><creator>Abreu, Adrian</creator><general>Cureus Inc</general><general>Cureus</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20230612</creationdate><title>Barriers of Care to Ovarian Cancer: A Scoping Review</title><author>Rizvi, Zehra ; Sharma, Kiran C ; Kunder, Viktor ; Abreu, Adrian</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c300t-d8f1f42a83549bf412114d954d1c602e378c238df473c68804a125164d1b683c3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>Cancer therapies</topic><topic>Epidemiology/Public Health</topic><topic>Health care access</topic><topic>Health disparities</topic><topic>Mortality</topic><topic>Obstetrics/Gynecology</topic><topic>Oncology</topic><topic>Ovarian cancer</topic><topic>Quality of care</topic><topic>Socioeconomic factors</topic><topic>Womens health</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Rizvi, Zehra</creatorcontrib><creatorcontrib>Sharma, Kiran C</creatorcontrib><creatorcontrib>Kunder, Viktor</creatorcontrib><creatorcontrib>Abreu, Adrian</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>AUTh Library subscriptions: ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Publicly Available Content (ProQuest)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Curēus (Palo Alto, CA)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Rizvi, Zehra</au><au>Sharma, Kiran C</au><au>Kunder, Viktor</au><au>Abreu, Adrian</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Barriers of Care to Ovarian Cancer: A Scoping Review</atitle><jtitle>Curēus (Palo Alto, CA)</jtitle><addtitle>Cureus</addtitle><date>2023-06-12</date><risdate>2023</risdate><volume>15</volume><issue>6</issue><spage>e40309</spage><epage>e40309</epage><pages>e40309-e40309</pages><issn>2168-8184</issn><eissn>2168-8184</eissn><abstract>Ovarian cancer is a leading cause of female cancer-related deaths, but patients continue to be diagnosed late. This subjects them to disease progression and possible death due to lack of early detection, despite earlier stage detection improving survival rates by significant percentages. Early detection and access to care are closely related. However, many barriers to high-quality care exist for patients and the majority of patients do not receive recommended care according to ovarian cancer treatment guidelines. In order to improve care for ovarian cancer patients and decrease healthcare disparities in accessing equitable care, it is important to acknowledge the current gaps in patient knowledge, healthcare availability, and physician practice. This scoping review explores the available evidence on ovarian cancer to identify these barriers to care in the effective treatment of ovarian cancer. Using both inclusion and exclusion criteria, results from the initial literature search were screened by the authors. After quality assessment and screening for relevance, 10 articles were included in the final review. The following themes emerged as barriers to care: hospital and physician-patient volumes, geographic distance from care facilities, patient and physician education, and demographic factors. Many patients were found to not receive guideline adherent care due to various barriers to care, whereas guideline adherent care was independently associated with factors such as patient proximity to a high-volume hospital, White race, and higher socioeconomic status. Several areas were identified as potential for increased patient and physician education, including treatment complications and patient resources. The evidence found that certain socioeconomic groups and racial minorities are often at higher risk for guideline non-adherent care. Additionally, the evidence showed a further need for physicians and healthcare providers to be provided with resources for post-cancer treatment, follow-up, and patient education. The findings of this review will provide health experts and patients with better insight into what barriers may exist so that guideline-adherent care can be better advocated for and met.</abstract><cop>United States</cop><pub>Cureus Inc</pub><pmid>37448421</pmid><doi>10.7759/cureus.40309</doi><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2168-8184
ispartof Curēus (Palo Alto, CA), 2023-06, Vol.15 (6), p.e40309-e40309
issn 2168-8184
2168-8184
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10337512
source Open Access: PubMed Central; Publicly Available Content (ProQuest)
subjects Cancer therapies
Epidemiology/Public Health
Health care access
Health disparities
Mortality
Obstetrics/Gynecology
Oncology
Ovarian cancer
Quality of care
Socioeconomic factors
Womens health
title Barriers of Care to Ovarian Cancer: A Scoping Review
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-10T22%3A27%3A21IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Barriers%20of%20Care%20to%20Ovarian%20Cancer:%20A%20Scoping%20Review&rft.jtitle=Cur%C4%93us%20(Palo%20Alto,%20CA)&rft.au=Rizvi,%20Zehra&rft.date=2023-06-12&rft.volume=15&rft.issue=6&rft.spage=e40309&rft.epage=e40309&rft.pages=e40309-e40309&rft.issn=2168-8184&rft.eissn=2168-8184&rft_id=info:doi/10.7759/cureus.40309&rft_dat=%3Cproquest_pubme%3E2844012455%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c300t-d8f1f42a83549bf412114d954d1c602e378c238df473c68804a125164d1b683c3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2844012455&rft_id=info:pmid/37448421&rfr_iscdi=true